These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


158 related items for PubMed ID: 28259946

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular design of the γδT cell receptor ectodomain encodes biologically fit ligand recognition in the absence of mechanosensing.
    Mallis RJ, Duke-Cohan JS, Das DK, Akitsu A, Luoma AM, Banik D, Stephens HM, Tetteh PW, Castro CD, Krahnke S, Hussey RE, Lawney B, Brazin KN, Reche PA, Hwang W, Adams EJ, Lang MJ, Reinherz EL.
    Proc Natl Acad Sci U S A; 2021 Jun 29; 118(26):. PubMed ID: 34172580
    [Abstract] [Full Text] [Related]

  • 5. Minimal amino acid exchange in human TCR constant regions fosters improved function of TCR gene-modified T cells.
    Sommermeyer D, Uckert W.
    J Immunol; 2010 Jun 01; 184(11):6223-31. PubMed ID: 20483785
    [Abstract] [Full Text] [Related]

  • 6. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
    van der Veken LT, Hagedoorn RS, van Loenen MM, Willemze R, Falkenburg JH, Heemskerk MH.
    Cancer Res; 2006 Mar 15; 66(6):3331-7. PubMed ID: 16540688
    [Abstract] [Full Text] [Related]

  • 7. Human TCR that incorporate CD3zeta induce highly preferred pairing between TCRalpha and beta chains following gene transfer.
    Sebestyén Z, Schooten E, Sals T, Zaldivar I, San José E, Alarcón B, Bobisse S, Rosato A, Szöllosi J, Gratama JW, Willemsen RA, Debets R.
    J Immunol; 2008 Jun 01; 180(11):7736-46. PubMed ID: 18490778
    [Abstract] [Full Text] [Related]

  • 8. An optimized single chain TCR scaffold relying on the assembly with the native CD3-complex prevents residual mispairing with endogenous TCRs in human T-cells.
    Knies D, Klobuch S, Xue SA, Birtel M, Echchannaoui H, Yildiz O, Omokoko T, Guillaume P, Romero P, Stauss H, Sahin U, Herr W, Theobald M, Thomas S, Voss RH.
    Oncotarget; 2016 Apr 19; 7(16):21199-221. PubMed ID: 27028870
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Evidence for a functional sidedness to the alphabetaTCR.
    Kuhns MS, Girvin AT, Klein LO, Chen R, Jensen KD, Newell EW, Huppa JB, Lillemeier BF, Huse M, Chien YH, Garcia KC, Davis MM.
    Proc Natl Acad Sci U S A; 2010 Mar 16; 107(11):5094-9. PubMed ID: 20202921
    [Abstract] [Full Text] [Related]

  • 12. Role of CD3 gamma in T cell receptor assembly.
    Dietrich J, Neisig A, Hou X, Wegener AM, Gajhede M, Geisler C.
    J Cell Biol; 1996 Feb 16; 132(3):299-310. PubMed ID: 8636209
    [Abstract] [Full Text] [Related]

  • 13. Promiscuous behavior of HPV16E6 specific T cell receptor beta chains hampers functional expression in TCR transgenic T cells, which can be restored in part by genetic modification.
    Scholten KB, Ruizendaal JJ, Graf M, Schoedl T, Kramer D, Meijer CJ, Man S, Hooijberg E.
    Cell Oncol; 2010 Feb 16; 32(1-2):43-56. PubMed ID: 20208133
    [Abstract] [Full Text] [Related]

  • 14. Imaging of T-cell receptor fused to CD3ζ reveals enhanced expression and improved pairing in living cells.
    Tao C, Shao H, Yuan Y, Wang H, Zhang W, Zheng W, Ma W, Huang S.
    Int J Mol Med; 2014 Sep 16; 34(3):849-55. PubMed ID: 25017903
    [Abstract] [Full Text] [Related]

  • 15. A single TCR alpha-chain with dominant peptide recognition in the allorestricted HER2/neu-specific T cell repertoire.
    Liang X, Weigand LU, Schuster IG, Eppinger E, van der Griendt JC, Schub A, Leisegang M, Sommermeyer D, Anderl F, Han Y, Ellwart J, Moosmann A, Busch DH, Uckert W, Peschel C, Krackhardt AM.
    J Immunol; 2010 Feb 01; 184(3):1617-29. PubMed ID: 20042572
    [Abstract] [Full Text] [Related]

  • 16. Optimization of T-cell Reactivity by Exploiting TCR Chain Centricity for the Purpose of Safe and Effective Antitumor TCR Gene Therapy.
    Ochi T, Nakatsugawa M, Chamoto K, Tanaka S, Yamashita Y, Guo T, Fujiwara H, Yasukawa M, Butler MO, Hirano N.
    Cancer Immunol Res; 2015 Sep 01; 3(9):1070-81. PubMed ID: 25943533
    [Abstract] [Full Text] [Related]

  • 17. Evolution of T cell receptor (TCR) alpha beta heterodimer assembly with the CD3 complex.
    Gouaillard C, Huchenq-Champagne A, Arnaud J, Chen Cl CL, Rubin B.
    Eur J Immunol; 2001 Dec 01; 31(12):3798-805. PubMed ID: 11745401
    [Abstract] [Full Text] [Related]

  • 18. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.
    Willemsen RA, Weijtens ME, Ronteltap C, Eshhar Z, Gratama JW, Chames P, Bolhuis RL.
    Gene Ther; 2000 Aug 01; 7(16):1369-77. PubMed ID: 10981663
    [Abstract] [Full Text] [Related]

  • 19. Generation of V α13/β21+T cell specific target CML cells by TCR gene transfer.
    Zha X, Xu L, Chen S, Yang L, Zhang Y, Lu Y, Yu Z, Li B, Wu X, Zheng W, Li Y.
    Oncotarget; 2016 Dec 20; 7(51):84246-84257. PubMed ID: 27713165
    [Abstract] [Full Text] [Related]

  • 20. Improved expression and reactivity of transduced tumor-specific TCRs in human lymphocytes by specific silencing of endogenous TCR.
    Okamoto S, Mineno J, Ikeda H, Fujiwara H, Yasukawa M, Shiku H, Kato I.
    Cancer Res; 2009 Dec 01; 69(23):9003-11. PubMed ID: 19903853
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.